Discover how amorphous Gd(OH)₃ nanocages are revolutionizing cancer therapy through enhanced enzymatic activities and targeted antitumor treatment approaches.
Explore the groundbreaking research on FEN1 inhibitors and their synergistic effects with PARP-targeting drugs in cancer therapy.